Information notice on the processing of personal data for healthcare professionals

Effective date: 11/06/2025

Pursuant to current legislation on the protection of personal data, including Regulation (EU) 2016/679 (GDPR), as well as other applicable data protection laws such as: the Swedish Act (2018:218) with supplementary provisions to the EU General Data Protection Regulation (in Swedish, Lag (2018:218) med kompletterande bestämmelser till EU:s dataskyddsförordning), the Danish Data Protection Act (Act No. 502 of 23 May 2018) (in Danish, Databeskyttelsesloven), the Finnish Data Protection Act (1050/2018) with supplementary provisions to the EU General Data Protection Regulation (in Finnish, Tietosuojalaki), the Icelandic Act No 90/2018 on data protection and the processing of personal data (in Icelandic, Lög nr. 90/2018 um persónuvernd og vinnslu persónuupplýsinga), and the Norwegian Data Protection Act (in Norwegian, Personopplysningsloven) (collectively referred to as the ”Privacy Legislation”), Recordati AB. (”Recordati” or the ”Data Controller”), provides you in your capacity as a healthcare professional (”HCP” or the ”Data Subject”) with the following information on the processing of your personal data collected and processed by Recordati as part of the performance of scientific information activities.

Personal data will be processed in compliance with the Privacy Legislation and the relevant applicable provisions issued by the competent data protection authorities.

2. Who processes your personal data

Data Controller:

The data controller is Recordati AB (company within the Recordati Group), with registered office in Berzeliusväg 8, 171 65 Solna, Sweden, registered with the Swedish Companies Registration Office (Sw. Bolagsverket) under org. nr. 556620-8350, which can be contacted at +46 771-670 670.

Data Protection Officer (hereinafter referred to as ”DPO”):

Recordati has appointed a DPO, who can be contacted at the following e-mail address: groupDPO@recordati.com, to whom Data Subjects can address any request regarding the processing of their personal data.

Authorised personnel:

All Recordati employees/collaborators who access, or will access, the personal data of the Data Subject operate/will operate under the direct authority of the Data Controller, and are appointed, pursuant to Article 29 of the GDPR, as persons authorized to process data having received, in this regard, adequate operating instructions.

3. Types of personal data processed

The personal data that will be processed are:

  1. personal and identification data of the Data Subject: this includes name and surname, date of birth, gender, fiscal code, professional title of the Data Subject, registration in the register of doctors;
  2. contact details of the Data Subject: this includes telephone number, e-mail address, address where the Data Subject carries out the professional activity;
  3. further information relating to the HCP profile: this includes, by way of example, interests, aptitude and approach in the scientific, technological or research fields, with respect to (i) technological applications and platforms at the service of medicine, (ii) therapeutic behaviours, (iii) the use of digital communication channels and (iv) interests in pharmaceutical products that Recordati may acquire from the Data Subject during visits and/or interviews with its medical representatives;
  4. data relating to the Data Subject’s interaction with Recordati services: this includes for example, opening of emails visualization of medical-scientific content, interactions of the Data Subject with e-mail links and content, duration of the Data Subject’s “engagement” on Recordati web pages, and web contents, participation in webinars, fruition of web content, etc.. Information about the cookies that Recordati processes in relation to the Data Subject’s engagement on Recordati web pages is described in Recordati’s Cookie Policy, which can be accessed on www.recordati.se website.

The Data Controller collects personal data from the following sources:

  • From the Data Subject directly, for example when carrying out scientific information activities via in-person meeting, we collect the information listed at a. to c. above
  • From your interaction with our online services and digital properties. We collect the information listed at b. to d. above in this way.
  • From third party service providers, which provides publicly available information, such as your address, and/or market research results.

Recordati will process the Data Subject’s personal data for the following purposes (the ”Purposes”):

Purpose of the processingLegal basisCategories of personal data and nature of the data providedRetention period
a) Carry out scientific information activities on drugs and products marketed by the Recordati Group and related activities (such as, by way of example, the presentation of medicines, the collection of requests and the supply of samples, as well as activities aimed at planning visits, orientation, guidance and monitoring of scientific information activities), in clinics, doctors’ offices and hospitals where HCPs carry out their professional activity.Art 6 (1)(f) GDPR: legitimate interest of the Data Controller to plan and carry out and optimize scientific information activities.For this purpose, we process the categories of personal data indicated in par. 3, lett. a., b. and c. above.Unless the Data Subject exercises the right to object, personal data will be stored for this purpose for a period of three (3) years from collection and recording within Recordati’s systems.
b) Carry out profiling activities based on the needs, interests and professional characteristics of HCPs in the scientific, technological and/or research fields for (i) analysis, internal management and planning of scientific information activities, and (ii) preparing personalized scientific information communications on the drugs and products marketed by the Recordati Group. In the event of refusal to provide data for personalized information scientific communications or objection to the processing, we inform you that the HCP may still receive general medical and scientific information and content from Recordati where done in compliance with Privacy Legislation and industry codes.Art. 6 (1) (f) GDPR: legitimate interest of the Data Controller to plan and improve the effectiveness, and carry out targeted and personalized scientific information activities in favour of HCPs.For this purpose, we process the categories of personal data indicated in par. 3, lett. a., c and d above.Unless the Data Subject exercises the right to object, personal data will be stored for this purpose for a period of three (3) years from collection and recording within Recordati’s systems.
c) To send scientific information communications on drugs, products and contact HCPs for promotional purposes and material marketed by the Recordati through e-mail phone or other digital web-based or communication tools (including sending invitations to participate in congresses, conferences or medical-scientific meetings, webinars and training events organized or sponsored by Recordati).Art. 6 (1) (a) GDPR: explicit consent of the Data Subject.For this purpose, we process all the categories of personal data indicated in par. 3 above.Personal data will be stored for this purpose until the Data Subject exercises the right to withdraw the consent given, which may take place at any time by contacting the Data Controller and/or the DPO and, in any case, for a period of three (3) years from the moment of expression of consent.
d) Share HCP data with the other companies belonging to the Recordati Group for the performance of their independent medical, scientific and promotional information purposes on the drugs and products marketed by them. The list of Recordati Group companies in each country is available on our website www.recordati.com or accessible here.Art. 6 (1) (a) GDPR: explicit consent of the Data Subject.For this purpose, we process the categories of personal data indicated in par. 3, lett. a. and b. above.Personal data will be stored until the Data Subject exercises the right to withdraw the consent given, which may take place at any time by contacting the Data Controller and/or the DPO and, in any case, for a period of three (3) years from the moment of expression of consent.

Unless indicated otherwise, the provision of personal data processed for the purposes indicated above is optional. In the event of refusal to provide your data, objection to processing or withdrawal of the consent previously given, Recordati will not be able to carry out the scientific information activities towards the HCP or the communications, as described above.

At the end of the storage periods identified above, the personal data of the Data Subjects will be deleted, unless there are further legitimate interests of the Data Controller for establishing, exercising or defending a legal claim that make their storage necessary, subject to minimization. In such case, the Data Controller will store the personal data for as long as necessary for this purpose.

The Data Controller also informs the Data Subject that at the time of collection and on the occasion of sending each communication made for the pursuit of the aforementioned Purpose, he/she has the possibility to: (i) withdraw, at any time, any consent given (see point 8 below as to how consent can be withdrawn); (ii) object to the processing of their personal data based on the legitimate interest of the Data Controller, in the manner better described in point 8 below.

5. Profiling

The Data Controller informs the Data Subjects that, with reference to the Purpose referred to in Paragraph 4 letter b) above (i.e. profiling activities), this activity has the sole purpose of identifying, on the basis of specific parameters identified by Recordati, in a precise and effective manner the professional and scientific profiles of the Data Subjects, as well as their specific professional needs so as to allow the same to optimize the performance of the activity of scientific information and the distribution of its contents. Profiling in this regard will enable the Data Controller to avoid sending mass medical-scientific communications to the recipient HCP, in circumstances where such communications may not be of interest to the HCP. Rather, these communications are limited only to those Data Subjects for which they are more relevant and adherent, according to the needs, interests and professional characteristics of the Data Subjects. Personalized communications may also be indirectly of benefit for the patients of the individual Data Subjects as they may increase the Data Subject’s awareness about specific relevant areas of diseases or medical practices.

In any case, the profiling mentioned above:

  • will not take place on the basis of an automated decision-making process from which legal or similarly significant effects derive for the Data Subjects pursuant to art. 22 of the GDPR;
  • will not affect the rights of the Data Subjects;
  • will not have any prolonged and permanent impact for Data Subjects, considering that the personal data collected by the Data Controller through its medical representatives are periodically updated.

Furthermore, considering that the processing in question is based on the legitimate interest of the Data Controller, the Data Controller guarantees that it has previously carried out an assessment aimed at ensuring the proportionality of the processing so that the rights and freedoms of the Data Subjects are not prejudiced, taking into account their reasonable expectations in relation to the specific processing activity carried out (so-called “Legitimate Interest Assessment” or “LIA”).

Data Subjects may request further information on the LIA referred to above, by contacting the Data Controller or the DPO at the addresses indicated below.

This is without prejudice to the right of the Data Subject to object to the performance of profiling activities at any time, in accordance with the procedures better described in point 8 below.

6. Recipients

The Data Controller informs the Data Subjects that their personal data may be communicated or made accessible for the Purposes listed above, and according to the legal bases listed above, to the following recipients or categories of recipients, as independent data controllers or, where necessary, data processors specifically selected and appointed pursuant to Article 28 of the GDPR which include:

  • suppliers of platforms for customer relationship management (CRM) and related technical assistance and maintenance services (all categories of personal data are shared);
  • companies that carry out market analyses/research (the categories of personal data shared are those indicated in par. 3, lett. a. above);
  • communication agencies and/or event organization (the categories of personal data shared are those indicated in par. 3, lett. a. above);
  • competent authorities, regulatory, prosecuting, law enforcement, tax or governmental authorities by virtue of legal provisions or regulations or European Union legislation (all categories of personal data may be shared);
  • in connection with a corporate transaction, a merger, consolidation, reorganisation, financing, change in control or acquisition of all or a portion of the Data Controller’s business by a third party (all categories of personal data may be shared);
  • other companies of the Recordati Group, subject to the consent of the Data Subject, when such consent is necessary under applicable Privacy Legislation (the categories of personal data shared are those indicated in par. 3, lett a. and b. above).

The complete list of recipients, including more details on the activities they are carrying out, the industry, sector and sub-sector and their headquarters, is kept at the Data Controller’s registered office and can be consulted upon request to be sent to the addresses indicated in point 8 of this policy.

7. Transfer of the personal data of the Data Subject abroad

The Data Subject’s personal data may be transferred outside the European Economic Area to countries which do not benefit from an adequacy decision by the European Commission, the Swiss Federal Data Protection and Information Commissioner (FDPIC) and UK Information Commissioner’s Office (ICO). Such transfers to non-EEA countries may only take place within the terms and with the guarantees provided for by the Privacy Legislation. In particular, the transfers will be carried out in accordance with the Standard Contractual Clauses (SCCs) adopted by the European Commission and recognized by Switzerland and UK, which provide appropriate safeguards for the protection of personal data. A copy of the SCCs or further information about these safeguards can be obtained by contacting us at groupDPO@recordati.com.

8. The rights of the Data Subject

The Data Controller informs the Data Subjects that they will always have the right to withdraw their consent at any time, where consent has been given. Data Subjects may also exercise any of the following rights (collectively, the ”Rights”):

  1. the ”right to access” and specifically to obtain confirmation of the existence or otherwise of Personal Data concerning him/her and their communication in intelligible form, as well as a copy of the personal data undergoing processing;
  2. the ”right to rectification”, i.e. the right to request the rectification or, if interested, the integration of personal data;
  3. the ”right to erasure”, i.e. the right to request the erasure or, transformation into anonymous form of personal data processed in violation of the law, including those whose retention is not necessary in relation to the Purposes for which the personal data were collected or subsequently processed;
  4. the ”right to restriction of processing”, i.e. the right to obtain from the Data Controller the limitation of processing in certain cases provided for under the Privacy Legislation;
  5. the ”right to data portability”, i.e. the right to receive (or to transmit directly to another data controller) personal data in a structured, commonly used and machine-readable format;
  6. the ”right to object”, i.e. the right to object, in whole or in part:
    • to the processing of personal data carried out by the Data Controller for its own legitimate interest;
    • to the processing of personal data carried out by the Data Controller for marketing or profiling purposes.

It is expressly understood, as provided for in Article 21 of the GDPR, that in the event of the exercise of the right to object by the Data Subject, the Data Controller will refrain from further processing the personal data unless the Data Controller demonstrates the existence of compelling legitimate reasons for proceeding with the processing that prevail over the interests, rights and freedoms of the Data Subject or for the ascertainment, the exercise or defence of a right in court.

The exercise of the foregoing rights is not subject to any formal constraint and is free of charge. The Data Controller may possibly require Data Subjects to verify their identity before taking further action following the request to exercise the rights referred to above.

In any case, the Data Subject may freely contact the DPO for all matters relating to the processing of his/her personal data and/or if he/she wishes to exercise his/her Rights:

  • by ordinary mail, to the address of the registered office of Recordati AB, with registered office in Berzeliusväg 8, 171 65 Solna, Sweden, In attention of the DPO;
  • by e-mail to the DPO: groupDPO@recordati.com.

9. Complaint

The Data Controller informs the Data Subject that, pursuant to the Privacy Legislation, he/she has the right to lodge a complaint with the competent Supervisory Authority (in particular in the Member State of his/her habitual residence, place of work or place of the alleged violation), if he/she is of the opinion that his/her personal data are processed in such a way as to involve violations of the GDPR. In addition, the Data Subject may contact the competent Supervisory Authority if the exercise of his/her rights is subject to delay, limitation or exclusion by the Data Controller.

In order to facilitate the Data Subject, the name and contact details of the European Union Supervisory Authorities, including the data protection authorities for Denmark, Finland, Iceland, Norway and Sweden, are available at the following link: Our Members | European Data Protection Board (europa.eu).

10. Update and revision

This information notice may be subject to amendments and additions from time to time. The Data Controller will notify the Data Subject directly when substantial amendments and additions will be made. The Data Controller may also notify the Data Subject in other ways from time to time, including by an announcement on the website.

Terms of use

Eligard.nu - (Last updated: 08 September 2021)

These terms of use (hereinafter “Terms of Use”) lay down the legally binding terms and conditions for using the services and information on this website at www.Eligard.nu (hereinafter “Website”). By entering this Website, you agree to be bound by the Terms of Use, which shall take effect immediately on your first visit of the Website and you agree to comply with them. If you do not agree to the below terms, please do not use the Website. The Website is maintained and operated by Recordati AB (seat: Berzeliusväg 8, 171 65 Solna; company registration number: 556620-8350; hereinafter “Company”, “we” or “us”). Company is a pharmaceutical company and the purpose of this Website is to provide information and raise awareness.

We reserve the right to revise or amend these Terms of Use at any time by updating this posting. You can determine when the Terms of Use was last revised by referring to the “last updated” legend at the top of this Terms of Use. We recommend that you print a copy of these terms for future reference. If there is any conflict between these Terms of Use and specific provisions appearing elsewhere on the Website, then these Terms of Use shall prevail. You are also responsible for ensuring that all persons who access our site through your internet connection are aware of these terms of use and other applicable terms and conditions, and that they comply with them. We may update and change our Website from time to time to reflect changes to our products, our users’ needs and our business priorities or for other reasons. We will try to give you reasonable notice of any major changes.

1. RESTRICTED USE

The content of this Website and any material published on it is the Company’s licensors intellectual property and we only provide to you a limited non-exclusive, non-transferable, non-assignable license for the use of the content made available at this Website. Those works are protected by copyright laws and treaties around the world. All such rights are reserved. Our status (and that of any identified contributors) as the authors of content on our Website must always be acknowledged. You must retain and make note of any comments pertaining to copyright and other intellectual rights on pages downloaded and printed from this Website. You are not permitted to use any of the Company’s name and trademarks without the prior approval from the respective Company. You may not, either in part or in full, distribute, modify or use the Website’s content, including the entire content, its images, audio and video materials, for public or commercial purposes without the prior written consent of the Company. You acknowledge and agree that, unless otherwise provided by law, all the content published on this Website is subject to copyright law and may not be used without the Company and the relevant author’s permission in any way other than in compliance with the conditions described in these Terms of Use or with the provisions set forth in the text on the given Website. The Company and other third persons will not assign and transfer to you any of the personal or proprietary interests or authorizations vested in the trademarks, patents, proprietary rights and other intellectual property rights that are so indicated.

2. LIMITATIONS AND EXCLUSIONS OF LIABILITY

This Website and its services are directed to healthcare professionals in Nordic countries (Denmark, Finland, Iceland, Norway, Sweden). You can visit and use the Website on your own risk. The content on this Website is provided for general information only and does not constitute any medical advice or diagnosis on which you should rely, nor is it intended in any way to incentivise the purchase of medicines or to promote any treatment for schizophrenia or other pathologies. It may not be construed as counselling or a recommendation, and such information may not serve as the basis for any decision or action, including any medical information posted on the Website, which cannot replace the detailed medical advice tailored to each patient’s needs. Neither this Website nor its content is intended to replace the advice or diagnosis of a healthcare professional. The Website may contain inaccuracies and typographical errors. We reserve the rght to change, correct and/or improve the current content as well as the programs and products described in the information without prior notice. We exclude all implied conditions, warranties, representations or other terms which may apply to this Website or any content on it. We do not exclude or limit in any way our liability to you where it would be unlawful to do so. To the extent permitted by applicable law, neither the Company nor other persons participating in the development and operation of this Website are liable for any fault, damage, loss of data, or any error in the content of the Website which may arise – directly, indirectly or accidentally – in connection with establishing a connection, browsing or downloading, when visiting this Website. We may suspend or withdraw or restrict the availability of all or any part of our Website for business and operational reasons without giving any explanation or prior notice.

Where this Website contains links to other websites and resources provided by third parties, these links are provided for your general information only. Such links should not be interpreted as approval by us of those linked websites or information you may obtain from them. We have no control over the contents of those websites or resources. The views expressed by other users on our Website do not represent our views or values.

4. RULES OF CONDUCT

While using the Website you agree to comply with all applicable laws, rules and regulations. We expect users of the Website to respect the law as well as the rights and dignity of others. You may not use our Website and the services we offer at our Website: in any way that breaches any applicable laws or regulations; in any way that is unlawful or fraudulent, or has any unlawful or fraudulent purpose or effect; for the purpose of harming or attempting to harm or otherwise violate the legal rights or dignity of others; to bully, insult, intimidate or humiliate any person. to impersonate any person or entity, including without limitation any representative of the Company; to transmit, or procure the sending of, any unsolicited or unauthorized advertising or other promotional materials or any other form of similar solicitation or for commercial purposes; to frame or mirror any part of the Website; to create a database by downloading and storing Website content; to knowingly transmit any data, send or upload any material that contains viruses, Trojan horses, worms, spyware, adware or any other harmful programs or similar computer code designed to adversely affect the operation of any computer software or hardware; or to gain unauthorized access to our Website, the server on which our Website is stored, or any server, computer or database connected to our Website. We will report any such breach to the relevant law enforcement authorities, and we will co-operate with those authorities by disclosing your identity to them. By using our Website, you also agree: Not to reproduce, duplicate, copy or re-sell any part of our site in contravention of the provisions of our Terms of Use. Not to access without authority, interfere with, damage or disrupt:

  • any part of our site;
  • any equipment or network on which our site is stored;
  • any software used in the provision of our site; or
  • any equipment or network or software owned or used by any third party.

If we are made aware of any activities, information or materials posted, transmitted, or otherwise made available through or in connection with the Website that may be a violation of these Terms of Use, we have the right, but not the obligation, to remove or disable access to the respective information or materials or to terminate your use of our websites with immediate effect.

5. TECHNICAL RESPONSIBILITY

We implemented state-of-the-art security technical and organizational measures to ensure the confidentiality, integrity, availability and resiliency of our Website. However, we understand that there is no 100% security and therefore we do not guarantee that our Website will be secure or free from bugs, 0-day vulnerabilities, malware or viruses. You are responsible for configuring your information technology, computer programs and platform in order to access our Website and for the proper usage thereof. We suggest using firewall and malware protection software. To the extent permitted by law, we are not liable and may not be held liable for any damage that your computer or any other of your property sustains when connecting to this Website or accessing, using and browsing through its content, including any adverse incident that may occur during downloading any material, data, text, image, video or audio material. In addition, tothe extent permitted by law, we are not liable for any direct or indirect damages, losses or costs that may arise from the improper operation or malfunction of the Website or from any similar causes.

6. DATA PROTECTION AND ACCESSIBILITY

Our Website Privacy Policy (“Privacy Policy”) and the Website Cookie Policy (“Cookie Policy”) set out the terms on which we process any personal data we collect from you, or that you provide to us. When accessing this Website, you must acknowledge to the terms of our Privacy Policy and the Cookie Policy. The terms of the Privacy Policy and the Cookie Policy are integral part of these Terms of Use. Some of the services offered on this Website do not require prior identification, so we provide you with access to the content of these services without you having to reveal your identity. However, in some cases, in order to visit certain sections, we must verify your identity that you are authorized to access those sections (especially if we display specific content that may only be directed to healthcare professionals according to the applicable laws). In case you decide not to provide the requested personal data, you accept the possibility that you may not be able to acess certain sections of this Website.
The professional content of the Website’s healthcare pages is reserved for registered users (healthcare professionals to whom the Website’s content is dedicated).

Our Website is made available free of charge. We do not guarantee that our Website, or any content on it, will always be available or be uninterrupted. We may suspend or withdraw or restrict the availability of all or any part of our site for business and operational reasons. We will try to give you reasonable notice of any suspension or withdrawal.
If you choose, or you are provided with, a user identification code, password or any other piece of information to verify your identity, then you must treat such information as confidential. You must not disclose it to any third party. We have the right to disable any user identification code or password, whether chosen by you or allocated by us, at any time, if in our reasonable opinion you have failed to comply with any of the provisions of these Terms of Use.
If you know or suspect that anyone other than you know your user identification code or password, you must promptly notify us at the contact page

You may link to our Website, provided you do so in a way that is fair and legal and does not damage our reputation or take advantage of it. You must not establish a link in such a way as to suggest any form of association, approval or endorsement on our part where none exists.

8. COMPLIANCE

Failure to comply with these Terms of Use constitutes a material breach of the terms upon which you are permitted to use our Website, and may result in our taking all or any of the following actions:

  • immediate, temporary or permanent withdrawal of your right to use our Website;

  • immediate, temporary or permanent removal of any posting or material uploaded by you to our Website;

  • issue of a warning;

  • legal proceedings against you for reimbursement of all costs on an indemnity basis (including, but not limited to, reasonable administrative and legal costs) resulting from the breach;

  • further legal action against you; or

  • disclosure of such information to law enforcement authorities as we reasonably feel is necessary.

9. APPLICABLE LAW AND JURISDICTION

Unless mandatory law provides otherwise, these Terms of Use, their subject matter and their formation (and any non-contractual disputes or claims) shall be governed by the laws of Sweden. We both agree to the exclusive jurisdiction of the courts of Stockholm.

10. CONTACT US

If you have any questions regarding the Website or these Terms of Use, please contact the Company via the contact information found on the contact page.

Cookie policy

Introduction

This Cookies Policy (the ”Policy”) explains how Recordati AB, the data controller, whose registered office is at Berzeliusväg 8, 171 65 Solna (hereinafter “Recordati”,we”, ”our” or ”us”) uses cookies and similar technologies to recognise you when you visit our website www.eligard.nu and its sub-domains (the “Website”). It explains what these technologies are and why we use them, as well as your rights to control our use of them.

What are cookies?

Cookies are small data files that are placed on your computer or mobile device when you visit a website. Cookies are widely used by website owners in order to make their websites work, or to work more efficiently, as well as to provide reporting information.

Cookies set by the website owner (in this case, www.recordati.com) are called “first party cookies”. Cookies set by parties other than the website owner are called “third party cookies”. Third party cookies enable third party features or functionality to be provided on or through the website (e.g. interactive content and analytics). The parties that set these third party cookies can recognise your computer both when it visits the website in question and also when it visits certain other websites.

Why do we use cookies?

We use first party and third party cookies for several reasons. Some cookies are required for technical reasons in order for our Website to operate, and we refer to these as “strictly necessary” cookies. Other cookies also enable us to track and target the interests of our users to enhance the experience on our Website. Third parties may serve cookies through our Website for analytics and other purposes. This is described in more detail below.

The specific types of first and third party cookies served through our Website and the purposes they perform are described in the table below:

Strictly necessary cookies: These cookies are essential to provide you with services available through our Website and to use some of its features, such as access to secure areas.

Performance cookies: These cookies are used to enhance and analyse the performance of our Website but are non-essential to its use. These cookies may collect information that is used either in aggregate form to help us understand how our Website is being used, the effectiveness of our marketing campaigns, or to help us customise our Website for you.

Who serves these cookies

Recordati AB, www.eligard.nu
Google Analytics, www.google.com
Recordati AB, https://www.recordati.com/en/  – Gesundheit Aps, https://gesundheitcph.com/

How to refuse these cookies

Because these cookies are essential to deliver the Website to you, you cannot refuse them.

You can block or delete them by changing your browser settings however, as described below under the heading “How can I control cookies?”

To refuse these cookies, please follow the instructions below under the heading “How can I control cookies?”

Alternatively, please click on the relevant opt-out link below:
https://www.google.com/policies/technologies/cookies/

How can I control cookies

You have the right to decide whether to accept or reject cookies. You can exercise your cookie preferences by clicking on the appropriate opt-out links provided in the cookie table above.

You can set or amend your web browser controls to accept or refuse cookies. If you choose to reject cookies, you may still use our website though your access to some functionality and areas of our website may be restricted. As the means by which you can refuse cookies through your web browser controls vary from browser-to-browser, you should visit your browser’s help menu for more information.

In addition, most advertising networks offer you a way to opt out of targeted advertising. If you would like to find out more information, please visit http://www.aboutads.info/choices/  or http://www.youronlinechoices.com.

We may update this Cookie Policy from time to time in order to reflect, for example, changes to the cookies we use or for other operational, legal or regulatory reasons. Please therefore re-visit this Cookie Policy regularly to stay informed about our use of cookies and related technologies.

The date at the top of this Cookie Policy indicates when it was last updated.

Where can I get further information?

If you have any questions about our use of cookies or other technologies, please email us at infonordic@recordati.com .

Aukaverkanir

Öll tilvik um ranga geymslu, undirbúning, blöndun og lyfjagjöf ELIGARD skal tilkynna beint til Recordati. Allar aukaverkanir sem grunur er um að tengist lyfinu skal tilkynna til Recordati og til Lyfjastofnunar. Aukaverkanatilkynningar má senda með tölvupósti til umboðsaðila

Recordati
customersafety@recordati.com

og til

Lyfjastofnunar
aukaverkun@lyfjastofnun.is

Eligard logo

Myndbönd

Leiðbeiningar fyrir undirbúning á Eligard® fortengdu sprautukerfi

Sækja myndbandið

Valmynd

Notkunarleiðbeiningar og leiðarvísir með Eligard® (leuprorelin)

Þessi vefsíða er ætluð sem stuðningsefni handa þeim sem vinna með krabbamein í blöðruhálskirtli. Hér er að finna upplýsingaefni, leiðbeiningar og lyfjafyrirmæli.

Recordati birtir efnið á þessari síðu til þess að meðferð með Eligard® (leuprorelin) skili hámarksárangri fyrir þig og sjúklinga þína.

Leiðbeiningar fyrir undirbúning á Eligard® fortengdu sprautukerfi

Í þessu myndbandi eru leiðbeiningar um undirbúning á Eligard® fortengdu sprautukerfi.

Sækja myndbandið

PDF

PDF

Leiðbeiningar fyrir undirbúning á Eligard® fortengdu sprautukerfi

Hægt er að prenta upplýsingarnar út.

Notkunarleiðbeiningar og leiðarvísir með Eligard® (leuprorelin)

Þessi vefsíða er ætluð sem stuðningsefni handa þeim sem vinna með krabbamein í blöðruhálskirtli. Hér er að finna upplýsingaefni, leiðbeiningar og lyfjafyrirmæli.

Recordati AB birtir efnið á þessari síðu til þess að meðferð með Eligard® (leuprorelin) skili hámarksárangri fyrir þig og sjúklinga þína

Nálgast má frekari upplýsingar um Eligard á Serlyfjaskra